-
1
-
-
33646890625
-
Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis
-
Aboul-Enein F., Weiser P., Hoftberger R., et al. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol 2006, 111:539-547.
-
(2006)
Acta Neuropathol
, vol.111
, pp. 539-547
-
-
Aboul-Enein, F.1
Weiser, P.2
Hoftberger, R.3
-
2
-
-
0028828168
-
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
-
Adelmann M., Wood J., Benzel I., et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 1995, 63:17-27.
-
(1995)
J Neuroimmunol
, vol.63
, pp. 17-27
-
-
Adelmann, M.1
Wood, J.2
Benzel, I.3
-
3
-
-
0037449737
-
Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17
-
Aggarwal S., Ghilardi N., Xie M.H., et al. Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
-
(2003)
J Biol Chem
, vol.278
, pp. 1910-1914
-
-
Aggarwal, S.1
Ghilardi, N.2
Xie, M.H.3
-
4
-
-
30044451754
-
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice
-
Aharoni R., Eilam R., Domev H., et al. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc Natl Acad Sci U S A 2005, 102:19045-19050.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 19045-19050
-
-
Aharoni, R.1
Eilam, R.2
Domev, H.3
-
5
-
-
49649090657
-
Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis
-
Aharoni R., Herschkovitz A., Eilam R., et al. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2008, 105:11358-11363.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 11358-11363
-
-
Aharoni, R.1
Herschkovitz, A.2
Eilam, R.3
-
6
-
-
0022995760
-
Defective suppressor cell function mediated by T8+ cell line from patients with progressive multiple sclerosis
-
Antel J., Bania M., Avertano N., et al. Defective suppressor cell function mediated by T8+ cell line from patients with progressive multiple sclerosis. J Immunol 1986, 137:3436-3439.
-
(1986)
J Immunol
, vol.137
, pp. 3436-3439
-
-
Antel, J.1
Bania, M.2
Avertano, N.3
-
7
-
-
46049093364
-
Th17 Cells and autoimmune encephalomyelitis (EAE/MS)
-
Aranami T., Yamamura T. Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int 2008, 57:115-120.
-
(2008)
Allergol Int
, vol.57
, pp. 115-120
-
-
Aranami, T.1
Yamamura, T.2
-
8
-
-
77950534540
-
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis
-
Axtell R.C., de Jong B.A., Boniface K., et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 2010, 16:406-412.
-
(2010)
Nat Med
, vol.16
, pp. 406-412
-
-
Axtell, R.C.1
de Jong, B.A.2
Boniface, K.3
-
9
-
-
0034618094
-
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
-
Babbe H., Roers A., Waisman A., et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393-404.
-
(2000)
J Exp Med
, vol.192
, pp. 393-404
-
-
Babbe, H.1
Roers, A.2
Waisman, A.3
-
10
-
-
0031469731
-
Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA
-
Bai X.F., Shi F.D., Xiao B.G., et al. Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA. J Neuroimmunol 1997, 80:65-75.
-
(1997)
J Neuroimmunol
, vol.80
, pp. 65-75
-
-
Bai, X.F.1
Shi, F.D.2
Xiao, B.G.3
-
11
-
-
34548443292
-
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis
-
Balatoni B., Storch M.K., Swoboda E.M., et al. FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis. Brain Res Bull 2007, 74:307-316.
-
(2007)
Brain Res Bull
, vol.74
, pp. 307-316
-
-
Balatoni, B.1
Storch, M.K.2
Swoboda, E.M.3
-
12
-
-
84863803849
-
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells
-
Barr T.A., Shen P., Brown S., et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 2012, 209:1001-1010.
-
(2012)
J Exp Med
, vol.209
, pp. 1001-1010
-
-
Barr, T.A.1
Shen, P.2
Brown, S.3
-
13
-
-
0036677420
-
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
-
Becher B., Durell B.G., Noelle R.J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 2002, 110:493-497.
-
(2002)
J Clin Invest
, vol.110
, pp. 493-497
-
-
Becher, B.1
Durell, B.G.2
Noelle, R.J.3
-
14
-
-
0347357773
-
IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis
-
Becher B., Durell B.G., Noelle R.J. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J Clin Invest 2003, 112:1186-1191.
-
(2003)
J Clin Invest
, vol.112
, pp. 1186-1191
-
-
Becher, B.1
Durell, B.G.2
Noelle, R.J.3
-
15
-
-
0029986881
-
The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease
-
Ben-Nun A., Mendel I., Bakimer R., et al. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease. J Neurol 1996, 243:S14-S22.
-
(1996)
J Neurol
, vol.243
-
-
Ben-Nun, A.1
Mendel, I.2
Bakimer, R.3
-
16
-
-
0033563260
-
Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis
-
Benson J.M., Stuckman S.S., Cox K.L., et al. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J Immunol 1999, 162:6247-6254.
-
(1999)
J Immunol
, vol.162
, pp. 6247-6254
-
-
Benson, J.M.1
Stuckman, S.S.2
Cox, K.L.3
-
17
-
-
0038790058
-
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
-
Berger T., Rubner P., Schautzer F., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003, 349:139-145.
-
(2003)
N Engl J Med
, vol.349
, pp. 139-145
-
-
Berger, T.1
Rubner, P.2
Schautzer, F.3
-
18
-
-
3142724732
-
Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis
-
Bettelli E., Sullivan B., Szabo S.J., et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J Exp Med 2004, 200:79-87.
-
(2004)
J Exp Med
, vol.200
, pp. 79-87
-
-
Bettelli, E.1
Sullivan, B.2
Szabo, S.J.3
-
19
-
-
2942537826
-
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta
-
Bielekova B., Richert N., Howard T., et al. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci U S A 2004, 101:8705-8708.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 8705-8708
-
-
Bielekova, B.1
Richert, N.2
Howard, T.3
-
20
-
-
33645812129
-
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis
-
Bielekova B., Catalfamo M., Reichert-Scrivner S., et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 2006, 103:5941-5946.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 5941-5946
-
-
Bielekova, B.1
Catalfamo, M.2
Reichert-Scrivner, S.3
-
21
-
-
65249138318
-
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis
-
Bielekova B., Howard T., Packer A.N., et al. Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch Neurol 2009, 66:483-489.
-
(2009)
Arch Neurol
, vol.66
, pp. 483-489
-
-
Bielekova, B.1
Howard, T.2
Packer, A.N.3
-
22
-
-
2942746494
-
A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response
-
Bischof F., Bins A., Durr M., et al. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response. J Immunol 2004, 173:600-606.
-
(2004)
J Immunol
, vol.173
, pp. 600-606
-
-
Bischof, F.1
Bins, A.2
Durr, M.3
-
23
-
-
0023927111
-
Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
-
Bitar D.M., Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol 1988, 112:364-370.
-
(1988)
Cell Immunol
, vol.112
, pp. 364-370
-
-
Bitar, D.M.1
Whitacre, C.C.2
-
24
-
-
65949111512
-
Identification of human S100A9 as a novel target for treatment of autoimmune diseasevia binding to quinoline-3-carboxamides
-
Bjork P., Bjork A., Vogl T., et al. Identification of human S100A9 as a novel target for treatment of autoimmune diseasevia binding to quinoline-3-carboxamides. PLoS Biol 2009, 7:e97.
-
(2009)
PLoS Biol
, vol.7
-
-
Bjork, P.1
Bjork, A.2
Vogl, T.3
-
25
-
-
0017277853
-
Biochemical findings in multiple sclerosis III Immunoglobulins of restricted heterogeneity and light chain distribution in cerebrospinal fluid of patients with multiple sclerosis
-
Bollengier F., Delmotte P., Lowenthal A. Biochemical findings in multiple sclerosis III Immunoglobulins of restricted heterogeneity and light chain distribution in cerebrospinal fluid of patients with multiple sclerosis. J Neurol 1976, 212:151-158.
-
(1976)
J Neurol
, vol.212
, pp. 151-158
-
-
Bollengier, F.1
Delmotte, P.2
Lowenthal, A.3
-
26
-
-
0021079164
-
Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis
-
Booss J., Esiri M.M., Tourtellotte W.W., et al. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983, 62:219-232.
-
(1983)
J Neurol Sci
, vol.62
, pp. 219-232
-
-
Booss, J.1
Esiri, M.M.2
Tourtellotte, W.W.3
-
27
-
-
0036710356
-
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis
-
Brunmark C., Runstrom A., Ohlsson L., et al. The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. J Neuroimmunol 2002, 130:163-172.
-
(2002)
J Neuroimmunol
, vol.130
, pp. 163-172
-
-
Brunmark, C.1
Runstrom, A.2
Ohlsson, L.3
-
28
-
-
0032902375
-
Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis
-
Burns J., Bartholomew B., Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol 1999, 45:33-39.
-
(1999)
Ann Neurol
, vol.45
, pp. 33-39
-
-
Burns, J.1
Bartholomew, B.2
Lobo, S.3
-
29
-
-
0032055153
-
Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis
-
Burt R.K., Padilla J., Begolka W.S., et al. Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis. Blood 1998, 91:2609-2616.
-
(1998)
Blood
, vol.91
, pp. 2609-2616
-
-
Burt, R.K.1
Padilla, J.2
Begolka, W.S.3
-
30
-
-
0028037782
-
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis
-
Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
-
(1994)
Science
, vol.265
, pp. 1237-1240
-
-
Chen, Y.1
Kuchroo, V.K.2
Inobe, J.3
-
31
-
-
33646433989
-
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
-
Chen Y., Langrish C.L., McKenzie B., et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 2006, 116:1317-1326.
-
(2006)
J Clin Invest
, vol.116
, pp. 1317-1326
-
-
Chen, Y.1
Langrish, C.L.2
McKenzie, B.3
-
32
-
-
0032882173
-
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
-
Coles A.J., Wing M.G., Molyneux P., et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999, 46:296-304.
-
(1999)
Ann Neurol
, vol.46
, pp. 296-304
-
-
Coles, A.J.1
Wing, M.G.2
Molyneux, P.3
-
33
-
-
54949143968
-
Alemtuzumab vs interferon beta-1a in early multiple sclerosis
-
Coles A.J., Compston D.A., Selmaj K.W., et al. Alemtuzumab vs interferon beta-1a in early multiple sclerosis. N Engl J Med 2008, 359:1786-1801.
-
(2008)
N Engl J Med
, vol.359
, pp. 1786-1801
-
-
Coles, A.J.1
Compston, D.A.2
Selmaj, K.W.3
-
34
-
-
0032528896
-
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy
-
Comabella M., Balashov K., Issazadeh S., et al. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest 1998, 102:671-678.
-
(1998)
J Clin Invest
, vol.102
, pp. 671-678
-
-
Comabella, M.1
Balashov, K.2
Issazadeh, S.3
-
35
-
-
41949135382
-
Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
-
Correale J., Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol 2008, 195:121-134.
-
(2008)
J Neuroimmunol
, vol.195
, pp. 121-134
-
-
Correale, J.1
Villa, A.2
-
36
-
-
0028215537
-
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
-
Critchfield J.M., Racke M.K., Zuniga-Pflucker J.C., et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994, 263:1139-1143.
-
(1994)
Science
, vol.263
, pp. 1139-1143
-
-
Critchfield, J.M.1
Racke, M.K.2
Zuniga-Pflucker, J.C.3
-
37
-
-
0037434789
-
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
-
Cua D.J., Sherlock J., Chen Y., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
-
(2003)
Nature
, vol.421
, pp. 744-748
-
-
Cua, D.J.1
Sherlock, J.2
Chen, Y.3
-
38
-
-
0027204621
-
Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production
-
Del Prete G., De Carli M., Almerigogna F., et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993, 150:353-360.
-
(1993)
J Immunol
, vol.150
, pp. 353-360
-
-
Del Prete, G.1
De Carli, M.2
Almerigogna, F.3
-
39
-
-
0037408259
-
Glatiramer acetate (Copaxone) therapy for multiple sclerosis
-
Dhib-Jalbut S. Glatiramer acetate (Copaxone) therapy for multiple sclerosis. Pharmacol Ther 2003, 98:245-255.
-
(2003)
Pharmacol Ther
, vol.98
, pp. 245-255
-
-
Dhib-Jalbut, S.1
-
40
-
-
0033857977
-
Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice
-
Dittel B.N., Urbania T.H., Janeway C.A. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. J Autoimmun 2000, 14:311-318.
-
(2000)
J Autoimmun
, vol.14
, pp. 311-318
-
-
Dittel, B.N.1
Urbania, T.H.2
Janeway, C.A.3
-
41
-
-
33644817756
-
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
-
Dutta R., McDonough J., Yin X., et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 2006, 59:478-489.
-
(2006)
Ann Neurol
, vol.59
, pp. 478-489
-
-
Dutta, R.1
McDonough, J.2
Yin, X.3
-
42
-
-
0345601517
-
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group
-
Ebers G.C., Hommes O., Hughes R.A.C., et al. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet 1998, 352:1498-1504.
-
(1998)
Lancet
, vol.352
, pp. 1498-1504
-
-
Ebers, G.C.1
Hommes, O.2
Hughes, R.A.C.3
-
43
-
-
0036795531
-
B cells regulate autoimmunity by provision of IL-10
-
Fillatreau S., Sweenie C.H., McGeachy M.J., et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
-
(2002)
Nat Immunol
, vol.3
, pp. 944-950
-
-
Fillatreau, S.1
Sweenie, C.H.2
McGeachy, M.J.3
-
44
-
-
35348970884
-
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis
-
Foster C.A., Howard L.M., Schweitzer A., et al. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J Pharmacol Exp Ther 2007, 323:469-475.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 469-475
-
-
Foster, C.A.1
Howard, L.M.2
Schweitzer, A.3
-
45
-
-
61649121740
-
FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage
-
Foster C.A., Mechtcheriakova D., Storch M.K., et al. FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol 2009, 19:254-266.
-
(2009)
Brain Pathol
, vol.19
, pp. 254-266
-
-
Foster, C.A.1
Mechtcheriakova, D.2
Storch, M.K.3
-
46
-
-
0030918326
-
Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis
-
Frei K., Eugster H.P., Bopst M., et al. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1997, 185:2177-2182.
-
(1997)
J Exp Med
, vol.185
, pp. 2177-2182
-
-
Frei, K.1
Eugster, H.P.2
Bopst, M.3
-
47
-
-
55549104692
-
Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis
-
Friese M.A., Jakobsen K.B., Friis L., et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat Med 2008, 14:1227-1235.
-
(2008)
Nat Med
, vol.14
, pp. 1227-1235
-
-
Friese, M.A.1
Jakobsen, K.B.2
Friis, L.3
-
48
-
-
66549130329
-
The relation between inflammation and neurodegeneration in multiple sclerosis brains
-
Frischer J.M., Bramow S., Dal-Bianco A., et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009, 132:1175-1189.
-
(2009)
Brain
, vol.132
, pp. 1175-1189
-
-
Frischer, J.M.1
Bramow, S.2
Dal-Bianco, A.3
-
49
-
-
0037379202
-
Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment
-
Fujino M., Funeshima N., Kitazawa Y., et al. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther 2003, 305:70-77.
-
(2003)
J Pharmacol Exp Ther
, vol.305
, pp. 70-77
-
-
Fujino, M.1
Funeshima, N.2
Kitazawa, Y.3
-
50
-
-
0027056539
-
Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy
-
Gaur A., Wiers B., Liu A., et al. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 1992, 258:1491-1494.
-
(1992)
Science
, vol.258
, pp. 1491-1494
-
-
Gaur, A.1
Wiers, B.2
Liu, A.3
-
51
-
-
84870953123
-
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
-
Getts D.R., Martin A.J., McCarthy D.P., et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 2012, 30:1217-1224.
-
(2012)
Nat Biotechnol
, vol.30
, pp. 1217-1224
-
-
Getts, D.R.1
Martin, A.J.2
McCarthy, D.P.3
-
52
-
-
84866423965
-
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
-
Gold R., Kappos L., Arnold D.L., et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012, 367:1098-1107.
-
(2012)
N Engl J Med
, vol.367
, pp. 1098-1107
-
-
Gold, R.1
Kappos, L.2
Arnold, D.L.3
-
53
-
-
0141832116
-
Lymphotoxin/light, lymphoid microenvironments and autoimmune disease
-
Gommerman J.L., Browning J.L. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 2003, 3:642-655.
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 642-655
-
-
Gommerman, J.L.1
Browning, J.L.2
-
54
-
-
84865261493
-
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
-
Gregory A.P., Dendrou C.A., Attfield K.E., et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012, 488:508-511.
-
(2012)
Nature
, vol.488
, pp. 508-511
-
-
Gregory, A.P.1
Dendrou, C.A.2
Attfield, K.E.3
-
55
-
-
27944499757
-
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
-
Haas J., Hug A., Viehover A., et al. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 2005, 35:3343-3352.
-
(2005)
Eur J Immunol
, vol.35
, pp. 3343-3352
-
-
Haas, J.1
Hug, A.2
Viehover, A.3
-
57
-
-
39049142995
-
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
-
Hauser S.L., Waubant E., Arnold D.L., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008, 358:676-688.
-
(2008)
N Engl J Med
, vol.358
, pp. 676-688
-
-
Hauser, S.L.1
Waubant, E.2
Arnold, D.L.3
-
58
-
-
70449418132
-
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial
-
Hawker K., O'Connor P., Freedman M.S., et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol 2009, 66:460-471.
-
(2009)
Ann Neurol
, vol.66
, pp. 460-471
-
-
Hawker, K.1
O'Connor, P.2
Freedman, M.S.3
-
59
-
-
0025218924
-
VLA proteins in the integrin family: structures, functions, and their role on leukocytes
-
Hemler M.E. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990, 8:365-400.
-
(1990)
Annu Rev Immunol
, vol.8
, pp. 365-400
-
-
Hemler, M.E.1
-
60
-
-
0023858086
-
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments
-
Higgins P.J., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 1988, 140:440-445.
-
(1988)
J Immunol
, vol.140
, pp. 440-445
-
-
Higgins, P.J.1
Weiner, H.L.2
-
61
-
-
0347785480
-
Control of regulatory T cell development by the transcription factor Foxp3
-
Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
-
(2003)
Science
, vol.299
, pp. 1057-1061
-
-
Hori, S.1
Nomura, T.2
Sakaguchi, S.3
-
62
-
-
56349101474
-
Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments
-
Huizinga R., Gerritsen W., Heijmans N., et al. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Neurobiol Dis 2008, 32:461-470.
-
(2008)
Neurobiol Dis
, vol.32
, pp. 461-470
-
-
Huizinga, R.1
Gerritsen, W.2
Heijmans, N.3
-
63
-
-
0035801332
-
A pathogenic role for myelin-specific cd8(+) T cells in a model for multiple sclerosis
-
Huseby E.S., Liggitt D., Brabb T., et al. A pathogenic role for myelin-specific cd8(+) T cells in a model for multiple sclerosis. J Exp Med 2001, 194:669-676.
-
(2001)
J Exp Med
, vol.194
, pp. 669-676
-
-
Huseby, E.S.1
Liggitt, D.2
Brabb, T.3
-
64
-
-
0026647293
-
Role of CD8+T cells in murine experimental allergic encephalomyelitis
-
Jiang H., Zhang S.I., Pernis B. Role of CD8+T cells in murine experimental allergic encephalomyelitis. Science 1992, 256:1213-1215.
-
(1992)
Science
, vol.256
, pp. 1213-1215
-
-
Jiang, H.1
Zhang, S.I.2
Pernis, B.3
-
65
-
-
0029082566
-
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial The Copolymer 1 Multiple Sclerosis Study Group
-
Johnson K.P., Brooks B.R., Cohen J.A., et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial The Copolymer 1 Multiple Sclerosis Study Group. Neurology 1995, 45:1268-1276.
-
(1995)
Neurology
, vol.45
, pp. 1268-1276
-
-
Johnson, K.P.1
Brooks, B.R.2
Cohen, J.A.3
-
66
-
-
11144357311
-
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship
-
Jonsson S., Andersson G., Fex T., et al. Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship. J Med Chem 2004, 47:2075-2088.
-
(2004)
J Med Chem
, vol.47
, pp. 2075-2088
-
-
Jonsson, S.1
Andersson, G.2
Fex, T.3
-
67
-
-
0002481864
-
A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases
-
Kabat E.A., Freedman D.A. A study of the crystalline albumin, gamma globulin and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases. Am J Med Sci 1950, 219:55-64.
-
(1950)
Am J Med Sci
, vol.219
, pp. 55-64
-
-
Kabat, E.A.1
Freedman, D.A.2
-
68
-
-
81555202418
-
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
-
Kappos L., Li D., Calabresi P.A., et al. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 2011, 378:1779-1787.
-
(2011)
Lancet
, vol.378
, pp. 1779-1787
-
-
Kappos, L.1
Li, D.2
Calabresi, P.A.3
-
69
-
-
0026604243
-
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation
-
Karussis D.M., Slavin S., Lehmann D., et al. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992, 148:1693-1698.
-
(1992)
J Immunol
, vol.148
, pp. 1693-1698
-
-
Karussis, D.M.1
Slavin, S.2
Lehmann, D.3
-
70
-
-
0027496152
-
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide
-
Karussis D.M., Lehmann D., Slavin S., et al. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann Neurol 1993, 34:654-660.
-
(1993)
Ann Neurol
, vol.34
, pp. 654-660
-
-
Karussis, D.M.1
Lehmann, D.2
Slavin, S.3
-
71
-
-
0027197490
-
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)
-
Karussis D.M., Lehmann D., Slavin S., et al. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide). Proc Natl Acad Sci U S A 1993, 90:6400-6404.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, pp. 6400-6404
-
-
Karussis, D.M.1
Lehmann, D.2
Slavin, S.3
-
72
-
-
33645283403
-
FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration
-
Kataoka H., Sugahara K., Shimano K., et al. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell Mol Immunol 2005, 2:439-448.
-
(2005)
Cell Mol Immunol
, vol.2
, pp. 439-448
-
-
Kataoka, H.1
Sugahara, K.2
Shimano, K.3
-
73
-
-
34948909646
-
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
-
Kebir H., Kreymborg K., Ifergan I., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173-1175.
-
(2007)
Nat Med
, vol.13
, pp. 1173-1175
-
-
Kebir, H.1
Kreymborg, K.2
Ifergan, I.3
-
74
-
-
0031570934
-
Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis -A comparison between oral and peripheral tolerance
-
Kennedy K.J., Smith W.S., Miller S.D., et al. Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis -A comparison between oral and peripheral tolerance. J Immunol 1997, 159:1036-1044.
-
(1997)
J Immunol
, vol.159
, pp. 1036-1044
-
-
Kennedy, K.J.1
Smith, W.S.2
Miller, S.D.3
-
75
-
-
0037311259
-
Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis
-
Kennel De March A., De Bouwerie M., Kolopp-Sarda M.N., et al. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J Neuroimmunol 2003, 135:117-125.
-
(2003)
J Neuroimmunol
, vol.135
, pp. 117-125
-
-
Kennel De March, A.1
De Bouwerie, M.2
Kolopp-Sarda, M.N.3
-
76
-
-
0026694021
-
Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice
-
Koh D.R., Fung-Leung W.P., Ho A., et al. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8 -/- mice. Science 1992, 256:1210-1213.
-
(1992)
Science
, vol.256
, pp. 1210-1213
-
-
Koh, D.R.1
Fung-Leung, W.P.2
Ho, A.3
-
78
-
-
34147128572
-
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
-
Korn T., Reddy J., Gao W., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007, 13:423-431.
-
(2007)
Nat Med
, vol.13
, pp. 423-431
-
-
Korn, T.1
Reddy, J.2
Gao, W.3
-
79
-
-
0032887020
-
Axonal pathology in multiple sclerosis A historical note
-
Kornek B., Lassmann H. Axonal pathology in multiple sclerosis A historical note. Brain Pathol 1999, 9:651-656.
-
(1999)
Brain Pathol
, vol.9
, pp. 651-656
-
-
Kornek, B.1
Lassmann, H.2
-
80
-
-
0033870097
-
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
-
Kornek B., Storch M.K., Weissert R., et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000, 157:267-276.
-
(2000)
Am J Pathol
, vol.157
, pp. 267-276
-
-
Kornek, B.1
Storch, M.K.2
Weissert, R.3
-
81
-
-
46949104323
-
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
-
Kroenke M.A., Carlson T.J., Andjelkovic A.V., et al. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 2008, 205:1535-1541.
-
(2008)
J Exp Med
, vol.205
, pp. 1535-1541
-
-
Kroenke, M.A.1
Carlson, T.J.2
Andjelkovic, A.V.3
-
82
-
-
33847677762
-
Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF
-
Kuhle J., Lindberg R.L., Regeniter A., et al. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF. J Neurol 2007, 254:160-168.
-
(2007)
J Neurol
, vol.254
, pp. 160-168
-
-
Kuhle, J.1
Lindberg, R.L.2
Regeniter, A.3
-
83
-
-
0036788406
-
Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time
-
Kuhlmann T., Lingfeld G., Bitsch A., et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002, 125:2202-2212.
-
(2002)
Brain
, vol.125
, pp. 2202-2212
-
-
Kuhlmann, T.1
Lingfeld, G.2
Bitsch, A.3
-
84
-
-
33751113922
-
CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis
-
Kumar M., Putzki N., Limmroth V., et al. CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J Neuroimmunol 2006, 180:178-184.
-
(2006)
J Neuroimmunol
, vol.180
, pp. 178-184
-
-
Kumar, M.1
Putzki, N.2
Limmroth, V.3
-
85
-
-
27644552194
-
Cortical demyelination and diffuse white matter injury in multiple sclerosis
-
Kutzelnigg A., Lucchinetti C.F., Stadelmann C., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005, 128:2705-2712.
-
(2005)
Brain
, vol.128
, pp. 2705-2712
-
-
Kutzelnigg, A.1
Lucchinetti, C.F.2
Stadelmann, C.3
-
86
-
-
0028102655
-
High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
-
Lafaille J.J., Nagashima K., Katsuki M., et al. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 1994, 78:399-408.
-
(1994)
Cell
, vol.78
, pp. 399-408
-
-
Lafaille, J.J.1
Nagashima, K.2
Katsuki, M.3
-
87
-
-
13244283212
-
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
-
Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
-
(2005)
J Exp Med
, vol.201
, pp. 233-240
-
-
Langrish, C.L.1
Chen, Y.2
Blumenschein, W.M.3
-
88
-
-
58149251898
-
Late developmental plasticity in the T helper 17 lineage
-
Lee Y.K., Turner H., Maynard C.L., et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
-
(2009)
Immunity
, vol.30
, pp. 92-107
-
-
Lee, Y.K.1
Turner, H.2
Maynard, C.L.3
-
89
-
-
58149159798
-
Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis
-
Lees J.R., Golumbek P.T., Sim J., et al. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J Exp Med 2008, 205:2633-2642.
-
(2008)
J Exp Med
, vol.205
, pp. 2633-2642
-
-
Lees, J.R.1
Golumbek, P.T.2
Sim, J.3
-
90
-
-
0026664422
-
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
-
Lehmann P.V., Forsthuber T., Miller A., et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992, 358:155-157.
-
(1992)
Nature
, vol.358
, pp. 155-157
-
-
Lehmann, P.V.1
Forsthuber, T.2
Miller, A.3
-
91
-
-
33947265597
-
Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1
-
Lehmann J.C., Listopad J.J., Rentzsch C.U., et al. Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1. J Invest Dermatol 2007, 127:835-845.
-
(2007)
J Invest Dermatol
, vol.127
, pp. 835-845
-
-
Lehmann, J.C.1
Listopad, J.J.2
Rentzsch, C.U.3
-
92
-
-
0033546665
-
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study
-
Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group
-
Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999, 53:457-465.
-
(1999)
Neurology
, vol.53
, pp. 457-465
-
-
-
93
-
-
0033566933
-
Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis
-
Lenz D.C., Wolf N.A., Swanborg R.H. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis. J Immunol 1999, 163:1763-1768.
-
(1999)
J Immunol
, vol.163
, pp. 1763-1768
-
-
Lenz, D.C.1
Wolf, N.A.2
Swanborg, R.H.3
-
94
-
-
77957759539
-
Characterization of brain lesions in a mouse model of progressive multiple sclerosis
-
Levy H., Assaf Y., Frenkel D. Characterization of brain lesions in a mouse model of progressive multiple sclerosis. Exp Neurol 2010, 226:148-158.
-
(2010)
Exp Neurol
, vol.226
, pp. 148-158
-
-
Levy, H.1
Assaf, Y.2
Frenkel, D.3
-
95
-
-
0023931606
-
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
-
Linington C., Bradl M., Lassmann H., et al. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 1988, 130:443-454.
-
(1988)
Am J Pathol
, vol.130
, pp. 443-454
-
-
Linington, C.1
Bradl, M.2
Lassmann, H.3
-
96
-
-
20444394379
-
Mechanisms of axonal degeneration in EAE - lessons from CNTF and MHC I knockout mice
-
Linker R.A., Sendtner M., Gold R. Mechanisms of axonal degeneration in EAE - lessons from CNTF and MHC I knockout mice. J Neurol Sci 2005, 233:167-172.
-
(2005)
J Neurol Sci
, vol.233
, pp. 167-172
-
-
Linker, R.A.1
Sendtner, M.2
Gold, R.3
-
97
-
-
0031916192
-
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
-
Liu J., Marino M.W., Wong G., et al. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998, 4:78-83.
-
(1998)
Nat Med
, vol.4
, pp. 78-83
-
-
Liu, J.1
Marino, M.W.2
Wong, G.3
-
98
-
-
33646029748
-
Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis
-
Liu L., Huang D., Matsui M., et al. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. J Immunol 2006, 176:4399-4409.
-
(2006)
J Immunol
, vol.176
, pp. 4399-4409
-
-
Liu, L.1
Huang, D.2
Matsui, M.3
-
99
-
-
33646596928
-
Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE
-
Liu Y., Teige I., Birnir B., et al. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006, 12:518-525.
-
(2006)
Nat Med
, vol.12
, pp. 518-525
-
-
Liu, Y.1
Teige, I.2
Birnir, B.3
-
100
-
-
0036105484
-
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
-
Lock C., Hermans G., Pedotti R., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002, 8:500-508.
-
(2002)
Nat Med
, vol.8
, pp. 500-508
-
-
Lock, C.1
Hermans, G.2
Pedotti, R.3
-
101
-
-
42249084849
-
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
-
Luger D., Silver P.B., Tang J., et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008, 205:799-810.
-
(2008)
J Exp Med
, vol.205
, pp. 799-810
-
-
Luger, D.1
Silver, P.B.2
Tang, J.3
-
102
-
-
84880559839
-
Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis
-
Lutterotti A., Yusef S., Sputtek A., et al. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci Transl Med 2013, 5:188ra75.
-
(2013)
Sci Transl Med
, vol.5
-
-
Lutterotti, A.1
Yusef, S.2
Sputtek, A.3
-
103
-
-
0032729174
-
B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide
-
Lyons J.A., San M., Happ M.P., et al. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 1999, 29:3432-3439.
-
(1999)
Eur J Immunol
, vol.29
, pp. 3432-3439
-
-
Lyons, J.A.1
San, M.2
Happ, M.P.3
-
104
-
-
1242340285
-
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis
-
Magliozzi R., Columba-Cabezas S., Serafini B., et al. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 2004, 148:11-23.
-
(2004)
J Neuroimmunol
, vol.148
, pp. 11-23
-
-
Magliozzi, R.1
Columba-Cabezas, S.2
Serafini, B.3
-
105
-
-
0028306935
-
Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats
-
Malotky M.K.H., Pope L., Miller S.D. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats. J Immunol 1994, 153:841-851.
-
(1994)
J Immunol
, vol.153
, pp. 841-851
-
-
Malotky, M.K.H.1
Pope, L.2
Miller, S.D.3
-
106
-
-
49949093283
-
Autologous haematopoietic stem-cell transplantation in multiple sclerosis
-
Mancardi G., Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 2008, 7:626-636.
-
(2008)
Lancet Neurol
, vol.7
, pp. 626-636
-
-
Mancardi, G.1
Saccardi, R.2
-
107
-
-
11144358095
-
Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association
-
Mantegazza R., Cristaldini P., Bernasconi P., et al. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. Int Immunol 2004, 16:559-565.
-
(2004)
Int Immunol
, vol.16
, pp. 559-565
-
-
Mantegazza, R.1
Cristaldini, P.2
Bernasconi, P.3
-
108
-
-
77951723662
-
Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population
-
Marquardt N., Wilk E., Pokoyski C., et al. Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population. Eur J Immunol 2010, 40:1428-1439.
-
(2010)
Eur J Immunol
, vol.40
, pp. 1428-1439
-
-
Marquardt, N.1
Wilk, E.2
Pokoyski, C.3
-
109
-
-
34948864286
-
Neurofascin as a novel target for autoantibody-mediated axonal injury
-
Mathey E.K., Derfuss T., Storch M.K., et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007, 204:2363-2372.
-
(2007)
J Exp Med
, vol.204
, pp. 2363-2372
-
-
Mathey, E.K.1
Derfuss, T.2
Storch, M.K.3
-
110
-
-
1642580757
-
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
-
Matloubian M., Lo C.G., Cinamon G., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
-
(2004)
Nature
, vol.427
, pp. 355-360
-
-
Matloubian, M.1
Lo, C.G.2
Cinamon, G.3
-
111
-
-
54949141219
-
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
-
Matsushita T., Yanaba K., Bouaziz J.D., et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420-3430.
-
(2008)
J Clin Invest
, vol.118
, pp. 3420-3430
-
-
Matsushita, T.1
Yanaba, K.2
Bouaziz, J.D.3
-
112
-
-
0344389016
-
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
-
Matusevicius D., Kivisakk P., He B., et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 1999, 5:101-104.
-
(1999)
Mult Scler
, vol.5
, pp. 101-104
-
-
Matusevicius, D.1
Kivisakk, P.2
He, B.3
-
113
-
-
0023628580
-
T cell subsets in multiple sclerosis Gradients at plaque borders and differences in nonplaque regions
-
McCallum K., Esiri M.M., Tourtellotte W.W., et al. T cell subsets in multiple sclerosis Gradients at plaque borders and differences in nonplaque regions. Brain 1987, 110:1297-1308.
-
(1987)
Brain
, vol.110
, pp. 1297-1308
-
-
McCallum, K.1
Esiri, M.M.2
Tourtellotte, W.W.3
-
114
-
-
60749107176
-
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo
-
McGeachy M.J., Chen Y., Tato C.M., et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 2009, 10:314-324.
-
(2009)
Nat Immunol
, vol.10
, pp. 314-324
-
-
McGeachy, M.J.1
Chen, Y.2
Tato, C.M.3
-
115
-
-
50349102854
-
B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases
-
McLaughlin K.A., Wucherpfennig K.W. B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol 2008, 98:121-149.
-
(2008)
Adv Immunol
, vol.98
, pp. 121-149
-
-
McLaughlin, K.A.1
Wucherpfennig, K.W.2
-
116
-
-
16244417773
-
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
-
McMahon E.J., Bailey S.L., Castenada C.V., et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005, 11:335-339.
-
(2005)
Nat Med
, vol.11
, pp. 335-339
-
-
McMahon, E.J.1
Bailey, S.L.2
Castenada, C.V.3
-
117
-
-
0029000750
-
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis
-
McRae B.L., Vanderlugt C.L., Dal Canto M.C., et al. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995, 182:75-85.
-
(1995)
J Exp Med
, vol.182
, pp. 75-85
-
-
McRae, B.L.1
Vanderlugt, C.L.2
Dal Canto, M.C.3
-
118
-
-
0026601932
-
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10PL mice
-
Merrill J.E., Kono D.H., Clayton J., et al. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10PL mice. Proc Natl Acad Sci U S A 1992, 89:574-578.
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 574-578
-
-
Merrill, J.E.1
Kono, D.H.2
Clayton, J.3
-
119
-
-
0030293682
-
Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
-
Meyer A.L., Benson J.M., Gienapp I.E., et al. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J Immunol 1996, 157:4230-4238.
-
(1996)
J Immunol
, vol.157
, pp. 4230-4238
-
-
Meyer, A.L.1
Benson, J.M.2
Gienapp, I.E.3
-
120
-
-
0018414685
-
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells
-
Miller S.D., Wetzig R.P., Claman H.N. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med 1979, 149:758-773.
-
(1979)
J Exp Med
, vol.149
, pp. 758-773
-
-
Miller, S.D.1
Wetzig, R.P.2
Claman, H.N.3
-
121
-
-
0026718660
-
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein V Hierarchy of suppression by myelin basic protein from different species
-
Miller A., Lider O., Al-Sabbagh A., et al. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein V Hierarchy of suppression by myelin basic protein from different species. J Neuroimmunol 1992, 39:243-250.
-
(1992)
J Neuroimmunol
, vol.39
, pp. 243-250
-
-
Miller, A.1
Lider, O.2
Al-Sabbagh, A.3
-
122
-
-
0037413467
-
A controlled trial of natalizumab for relapsing multiple sclerosis
-
Miller D.H., Khan O.A., Sheremata W.A., et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003, 348:15-23.
-
(2003)
N Engl J Med
, vol.348
, pp. 15-23
-
-
Miller, D.H.1
Khan, O.A.2
Sheremata, W.A.3
-
123
-
-
84864117759
-
Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod
-
Mishra M.K., Wang J., Silva C., et al. Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod. Am J Pathol 2012, 181:642-651.
-
(2012)
Am J Pathol
, vol.181
, pp. 642-651
-
-
Mishra, M.K.1
Wang, J.2
Silva, C.3
-
124
-
-
79951907091
-
Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis
-
Monson N.L., Cravens P., Hussain R., et al. Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. PLoS One 2011, 6:e17103.
-
(2011)
PLoS One
, vol.6
-
-
Monson, N.L.1
Cravens, P.2
Hussain, R.3
-
125
-
-
3242740010
-
Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies
-
Montero E., Nussbaum G., Kaye J.F., et al. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J Autoimmun 2004, 23:1-7.
-
(2004)
J Autoimmun
, vol.23
, pp. 1-7
-
-
Montero, E.1
Nussbaum, G.2
Kaye, J.F.3
-
126
-
-
0029869119
-
Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis
-
Moreau T., Coles A., Wing M., et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996, 119:225-237.
-
(1996)
Brain
, vol.119
, pp. 225-237
-
-
Moreau, T.1
Coles, A.2
Wing, M.3
-
127
-
-
0022640843
-
Two types of murine helper T cell clones I Definition according to profiles of lymphokine activities and secreted proteins
-
Mosmann T.R., Cherwinski H., Bond M.W., et al. Two types of murine helper T cell clones I Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
-
(1986)
J Immunol
, vol.136
, pp. 2348-2357
-
-
Mosmann, T.R.1
Cherwinski, H.2
Bond, M.W.3
-
128
-
-
0029079852
-
Induction of MHC class I genes in neurons
-
Neumann H., Cavalie A., Jenne D.E., et al. Induction of MHC class I genes in neurons. Science 1995, 269:549-552.
-
(1995)
Science
, vol.269
, pp. 549-552
-
-
Neumann, H.1
Cavalie, A.2
Jenne, D.E.3
-
129
-
-
0034624942
-
Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results North American Linomide Investigators
-
Noseworthy J.H., Wolinsky J.S., Lublin F.D., et al. Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results North American Linomide Investigators. Neurology 2000, 54:1726-1733.
-
(2000)
Neurology
, vol.54
, pp. 1726-1733
-
-
Noseworthy, J.H.1
Wolinsky, J.S.2
Lublin, F.D.3
-
130
-
-
0031661686
-
The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network
-
Ockenfels H.M., Schultewolter T., Ockenfels G., et al. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998, 139:390-395.
-
(1998)
Br J Dermatol
, vol.139
, pp. 390-395
-
-
Ockenfels, H.M.1
Schultewolter, T.2
Ockenfels, G.3
-
132
-
-
0001158889
-
Experimental disseminated encephalomyelitis in white mice
-
Olitsky P.K., Yager R.H. Experimental disseminated encephalomyelitis in white mice. J Exp Med 1949, 90:213-223.
-
(1949)
J Exp Med
, vol.90
, pp. 213-223
-
-
Olitsky, P.K.1
Yager, R.H.2
-
133
-
-
0032538918
-
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis
-
Olivares-Villagomez D., Wang Y., Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 1998, 188:1883-1894.
-
(1998)
J Exp Med
, vol.188
, pp. 1883-1894
-
-
Olivares-Villagomez, D.1
Wang, Y.2
Lafaille, J.J.3
-
134
-
-
0023157207
-
Role of the clotting system in the pathogenesis of neuroimmunologic disease
-
Paterson P.Y., Koh C.S., Kwaan H.C. Role of the clotting system in the pathogenesis of neuroimmunologic disease. Fed Proc 1987, 46:91-96.
-
(1987)
Fed Proc
, vol.46
, pp. 91-96
-
-
Paterson, P.Y.1
Koh, C.S.2
Kwaan, H.C.3
-
135
-
-
0030741166
-
Production of cytokines by human B cells in health and disease
-
Pistoia V. Production of cytokines by human B cells in health and disease. Immunol Today 1997, 18:343-350.
-
(1997)
Immunol Today
, vol.18
, pp. 343-350
-
-
Pistoia, V.1
-
136
-
-
33847669192
-
CD4+ CD25+[corrected] regulatory T cells render naive CD4+ CD25-T cells anergic and suppressive
-
Qiao M., Thornton A.M., Shevach E.M. CD4+ CD25+[corrected] regulatory T cells render naive CD4+ CD25-T cells anergic and suppressive. Immunology 2007, 120:447-455.
-
(2007)
Immunology
, vol.120
, pp. 447-455
-
-
Qiao, M.1
Thornton, A.M.2
Shevach, E.M.3
-
137
-
-
0030071366
-
Intravenous antigen administration as a therapy for autoimmune demyelinating disease
-
Racke M.K., Critchfield J.M., Quigley L., et al. Intravenous antigen administration as a therapy for autoimmune demyelinating disease. Ann Neurol 1996, 39:46-56.
-
(1996)
Ann Neurol
, vol.39
, pp. 46-56
-
-
Racke, M.K.1
Critchfield, J.M.2
Quigley, L.3
-
138
-
-
65249175159
-
C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
-
Reboldi A., Coisne C., Baumjohann D., et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009, 10:514-523.
-
(2009)
Nat Immunol
, vol.10
, pp. 514-523
-
-
Reboldi, A.1
Coisne, C.2
Baumjohann, D.3
-
139
-
-
0031439343
-
Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible
-
Redford E.J., Kapoor R., Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997, 120:2149-2157.
-
(1997)
Brain
, vol.120
, pp. 2149-2157
-
-
Redford, E.J.1
Kapoor, R.2
Smith, K.J.3
-
140
-
-
0030926207
-
Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans
-
Rep M.H., van Oosten B.W., Roos M.T., et al. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J Clin Invest 1997, 99:2225-2231.
-
(1997)
J Clin Invest
, vol.99
, pp. 2225-2231
-
-
Rep, M.H.1
van Oosten, B.W.2
Roos, M.T.3
-
141
-
-
2642698865
-
Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice
-
Riminton D.S., Korner H., Strickland D.H., et al. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice. J Exp Med 1998, 187:1517-1528.
-
(1998)
J Exp Med
, vol.187
, pp. 1517-1528
-
-
Riminton, D.S.1
Korner, H.2
Strickland, D.H.3
-
142
-
-
34548142973
-
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results
-
Rose J.W., Burns J.B., Bjorklund J., et al. Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology 2007, 69:785-789.
-
(2007)
Neurology
, vol.69
, pp. 785-789
-
-
Rose, J.W.1
Burns, J.B.2
Bjorklund, J.3
-
143
-
-
0025000863
-
An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
-
Ruddle N.H., Bergman C.M., McGrath K.M., et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 1990, 172:1193-1200.
-
(1990)
J Exp Med
, vol.172
, pp. 1193-1200
-
-
Ruddle, N.H.1
Bergman, C.M.2
McGrath, K.M.3
-
144
-
-
33745162188
-
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
-
Schilling S., Goelz S., Linker R., et al. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol 2006, 145:101-107.
-
(2006)
Clin Exp Immunol
, vol.145
, pp. 101-107
-
-
Schilling, S.1
Goelz, S.2
Linker, R.3
-
145
-
-
84859151160
-
Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity
-
Schulze-Topphoff U., Shetty A., Varrin-Doyer M., et al. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity. PLoS One 2012, 7:e33797.
-
(2012)
PLoS One
, vol.7
-
-
Schulze-Topphoff, U.1
Shetty, A.2
Varrin-Doyer, M.3
-
146
-
-
48849087125
-
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
-
Segal B.M., Constantinescu C.S., Raychaudhuri A., et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 2008, 7:796-804.
-
(2008)
Lancet Neurol
, vol.7
, pp. 796-804
-
-
Segal, B.M.1
Constantinescu, C.S.2
Raychaudhuri, A.3
-
147
-
-
0026094706
-
Anti-tumor necrosis factor therapy abrogates autoimmune demyelination
-
Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991, 30:694-700.
-
(1991)
Ann Neurol
, vol.30
, pp. 694-700
-
-
Selmaj, K.1
Raine, C.S.2
Cross, A.H.3
-
148
-
-
2442708947
-
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis
-
Serafini B., Rosicarelli B., Magliozzi R., et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004, 14:164-174.
-
(2004)
Brain Pathol
, vol.14
, pp. 164-174
-
-
Serafini, B.1
Rosicarelli, B.2
Magliozzi, R.3
-
149
-
-
0024268211
-
Increased diameter of demyelinated axons in chronic multiple sclerosis of the spinal cord
-
Shintaku M., Hirano A., Llena J.F. Increased diameter of demyelinated axons in chronic multiple sclerosis of the spinal cord. Neuropathol Appl Neurobiol 1988, 14:505-510.
-
(1988)
Neuropathol Appl Neurobiol
, vol.14
, pp. 505-510
-
-
Shintaku, M.1
Hirano, A.2
Llena, J.F.3
-
150
-
-
33645289121
-
CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs
-
Shiow L.R., Rosen D.B., Brdickova N., et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006, 440:540-544.
-
(2006)
Nature
, vol.440
, pp. 540-544
-
-
Shiow, L.R.1
Rosen, D.B.2
Brdickova, N.3
-
151
-
-
77957056123
-
In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis
-
Siffrin V., Radbruch H., Glumm R., et al. In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 2010, 33:424-436.
-
(2010)
Immunity
, vol.33
, pp. 424-436
-
-
Siffrin, V.1
Radbruch, H.2
Glumm, R.3
-
152
-
-
0034991196
-
Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes
-
Slavin A.J., Maron R., Weiner H.L. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol 2001, 13:825-833.
-
(2001)
Int Immunol
, vol.13
, pp. 825-833
-
-
Slavin, A.J.1
Maron, R.2
Weiner, H.L.3
-
153
-
-
0035067635
-
Electrically active axons degenerate when exposed to nitric oxide
-
Smith K.J., Kapoor R., Hall S.M., et al. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001, 49:470-476.
-
(2001)
Ann Neurol
, vol.49
, pp. 470-476
-
-
Smith, K.J.1
Kapoor, R.2
Hall, S.M.3
-
154
-
-
22144479728
-
Differential induction of IgE-mediated anaphylaxis after soluble vs cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis
-
Smith C.E., Eagar T.N., Strominger J.L., et al. Differential induction of IgE-mediated anaphylaxis after soluble vs cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2005, 102:9595-9600.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 9595-9600
-
-
Smith, C.E.1
Eagar, T.N.2
Strominger, J.L.3
-
155
-
-
28544450761
-
Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis
-
Sriram S., Steiner I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 2005, 58:939-945.
-
(2005)
Ann Neurol
, vol.58
, pp. 939-945
-
-
Sriram, S.1
Steiner, I.2
-
156
-
-
0019978208
-
Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions
-
Sriram S., Solomon D., Rouse R.V., et al. Identification of T cell subsets and B lymphocytes in mouse brain experimental allergic encephalitis lesions. J Immunol 1982, 129:1649-1651.
-
(1982)
J Immunol
, vol.129
, pp. 1649-1651
-
-
Sriram, S.1
Solomon, D.2
Rouse, R.V.3
-
157
-
-
0020549560
-
Administration of myelin basic protein-coupled spleen cells prevents experimental allergic encephalitis
-
Sriram S., Schwartz G., Steinman L. Administration of myelin basic protein-coupled spleen cells prevents experimental allergic encephalitis. Cell Immunol 1983, 75:378-382.
-
(1983)
Cell Immunol
, vol.75
, pp. 378-382
-
-
Sriram, S.1
Schwartz, G.2
Steinman, L.3
-
158
-
-
0033168629
-
Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response
-
Stefferl A., Brehm U., Storch M., et al. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol 1999, 163:40-49.
-
(1999)
J Immunol
, vol.163
, pp. 40-49
-
-
Stefferl, A.1
Brehm, U.2
Storch, M.3
-
159
-
-
40449089827
-
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells
-
Stromnes I.M., Cerretti L.M., Liggitt D., et al. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 2008, 14:337-342.
-
(2008)
Nat Med
, vol.14
, pp. 337-342
-
-
Stromnes, I.M.1
Cerretti, L.M.2
Liggitt, D.3
-
160
-
-
0035877190
-
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice
-
Sun D., Whitaker J.N., Huang Z., et al. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol 2001, 166:7579-7587.
-
(2001)
J Immunol
, vol.166
, pp. 7579-7587
-
-
Sun, D.1
Whitaker, J.N.2
Huang, Z.3
-
161
-
-
0036318944
-
A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination
-
Svensson L., Abdul-Majid K.B., Bauer J., et al. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur J Immunol 2002, 32:1939-1946.
-
(2002)
Eur J Immunol
, vol.32
, pp. 1939-1946
-
-
Svensson, L.1
Abdul-Majid, K.B.2
Bauer, J.3
-
162
-
-
0035707638
-
Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity
-
Swanborg R.H. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity. Immunol Rev 2001, 184:129-135.
-
(2001)
Immunol Rev
, vol.184
, pp. 129-135
-
-
Swanborg, R.H.1
-
163
-
-
0015103005
-
Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide
-
Teitelbaum D., Meshorer A., Hirshfeld T., et al. Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol 1971, 1:242-248.
-
(1971)
Eur J Immunol
, vol.1
, pp. 242-248
-
-
Teitelbaum, D.1
Meshorer, A.2
Hirshfeld, T.3
-
164
-
-
0016290415
-
Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer
-
Teitelbaum D., Webb C., Bree M., et al. Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer. Clin Immunol Immunopathol 1974, 3:256-262.
-
(1974)
Clin Immunol Immunopathol
, vol.3
, pp. 256-262
-
-
Teitelbaum, D.1
Webb, C.2
Bree, M.3
-
165
-
-
0029916716
-
Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses
-
Teitelbaum D., Fridkis-Hareli M., Arnon R., et al. Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses. J Neuroimmunol 1996, 64:209-217.
-
(1996)
J Neuroimmunol
, vol.64
, pp. 209-217
-
-
Teitelbaum, D.1
Fridkis-Hareli, M.2
Arnon, R.3
-
166
-
-
11144297111
-
Biological markers in CSF and blood for axonal degeneration in multiple sclerosis
-
Teunissen C.E., Dijkstra C., Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol 2005, 4:32-41.
-
(2005)
Lancet Neurol
, vol.4
, pp. 32-41
-
-
Teunissen, C.E.1
Dijkstra, C.2
Polman, C.3
-
167
-
-
83555174399
-
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor
-
Thone J., Ellrichmann G., Seubert S., et al. Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor. Am J Pathol 2012, 180:267-274.
-
(2012)
Am J Pathol
, vol.180
, pp. 267-274
-
-
Thone, J.1
Ellrichmann, G.2
Seubert, S.3
-
168
-
-
0034026891
-
Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor
-
Tran E.H., Kuziel W.A., Owens T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor. Eur J Immunol 2000, 30:1410-1415.
-
(2000)
Eur J Immunol
, vol.30
, pp. 1410-1415
-
-
Tran, E.H.1
Kuziel, W.A.2
Owens, T.3
-
169
-
-
0030899404
-
Diversity and plasticity of self recognition during the development of multiple sclerosis
-
Tuohy V.K., Yu M., Weinstock-Guttman B., et al. Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 1997, 99:1682-1690.
-
(1997)
J Clin Invest
, vol.99
, pp. 1682-1690
-
-
Tuohy, V.K.1
Yu, M.2
Weinstock-Guttman, B.3
-
170
-
-
33846919872
-
Peripheral tolerance Induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis
-
Turley D.M., Miller S.D. Peripheral tolerance Induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J Immunol 2007, 178:2212-2220.
-
(2007)
J Immunol
, vol.178
, pp. 2212-2220
-
-
Turley, D.M.1
Miller, S.D.2
-
171
-
-
33744936550
-
IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production
-
Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 2006, 176:7768-7774.
-
(2006)
J Immunol
, vol.176
, pp. 7768-7774
-
-
Vaknin-Dembinsky, A.1
Balashov, K.2
Weiner, H.L.3
-
172
-
-
0030880011
-
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial
-
van Oosten B.W., Lai M., Hodgkinson S., et al. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 1997, 49:351-357.
-
(1997)
Neurology
, vol.49
, pp. 351-357
-
-
van Oosten, B.W.1
Lai, M.2
Hodgkinson, S.3
-
173
-
-
17344363488
-
The functional significance of epitope spreading and its regulation by co-stimulatory molecules
-
Vanderlugt C.L., Begolka W.S., Neville K.L., et al. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev 1998, 164:63-72.
-
(1998)
Immunol Rev
, vol.164
, pp. 63-72
-
-
Vanderlugt, C.L.1
Begolka, W.S.2
Neville, K.L.3
-
174
-
-
33744904725
-
Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression
-
Venken K., Hellings N., Hensen K., et al. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J Neurosci Res 2006, 83:1432-1446.
-
(2006)
J Neurosci Res
, vol.83
, pp. 1432-1446
-
-
Venken, K.1
Hellings, N.2
Hensen, K.3
-
175
-
-
1842732224
-
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
-
Viglietta V., Baecher-Allan C., Weiner H.L., et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004, 199:971-979.
-
(2004)
J Exp Med
, vol.199
, pp. 971-979
-
-
Viglietta, V.1
Baecher-Allan, C.2
Weiner, H.L.3
-
176
-
-
0037066132
-
Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS
-
Villar L.M., Masjuan J., Gonzalez-Porque P., et al. Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS. Neurology 2002, 58:824-826.
-
(2002)
Neurology
, vol.58
, pp. 824-826
-
-
Villar, L.M.1
Masjuan, J.2
Gonzalez-Porque, P.3
-
177
-
-
0021913219
-
Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker
-
Waldor M.K., Sriram S., Hardy R., et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 1985, 227:415-417.
-
(1985)
Science
, vol.227
, pp. 415-417
-
-
Waldor, M.K.1
Sriram, S.2
Hardy, R.3
-
178
-
-
77955031189
-
Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?
-
Warnke C., Menge T., Hartung H.P., et al. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?. Arch Neurol 2010, 67:923-930.
-
(2010)
Arch Neurol
, vol.67
, pp. 923-930
-
-
Warnke, C.1
Menge, T.2
Hartung, H.P.3
-
179
-
-
0027467163
-
Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue
-
Warren K.G., Catz I. Autoantibodies to myelin basic protein within multiple sclerosis central nervous system tissue. J Neurol Sci 1993, 115:169-176.
-
(1993)
J Neurol Sci
, vol.115
, pp. 169-176
-
-
Warren, K.G.1
Catz, I.2
-
180
-
-
3242683494
-
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
-
Webb M., Tham C.S., Lin F.F., et al. Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol 2004, 153:108-121.
-
(2004)
J Neuroimmunol
, vol.153
, pp. 108-121
-
-
Webb, M.1
Tham, C.S.2
Lin, F.F.3
-
181
-
-
77956360533
-
B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
-
Weber M.S., Prod'homme T., Patarroyo J.C., et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann Neurol 2010, 68:369-383.
-
(2010)
Ann Neurol
, vol.68
, pp. 369-383
-
-
Weber, M.S.1
Prod'homme, T.2
Patarroyo, J.C.3
-
182
-
-
77956649428
-
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
-
Wegner C., Stadelmann C., Pfortner R., et al. Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 2010, 227:133-143.
-
(2010)
J Neuroimmunol
, vol.227
, pp. 133-143
-
-
Wegner, C.1
Stadelmann, C.2
Pfortner, R.3
-
183
-
-
14544294320
-
Current issues in the treatment of human diseases by mucosal tolerance
-
Weiner H.L. Current issues in the treatment of human diseases by mucosal tolerance. Ann N Y Acad Sci 2004, 1029:211-224.
-
(2004)
Ann N Y Acad Sci
, vol.1029
, pp. 211-224
-
-
Weiner, H.L.1
-
184
-
-
0026042008
-
Oral tolerance in experimental autoimmune encephalomyelitis: III Evidence for clonal anergy
-
Whitacre C.C., Gienapp I.E., Orosz C.G., et al. Oral tolerance in experimental autoimmune encephalomyelitis: III Evidence for clonal anergy. J Immunol 1991, 147:2155-2163.
-
(1991)
J Immunol
, vol.147
, pp. 2155-2163
-
-
Whitacre, C.C.1
Gienapp, I.E.2
Orosz, C.G.3
-
185
-
-
0030587910
-
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis
-
Willenborg D.O., Fordham S., Bernard C.C., et al. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996, 157:3223-3227.
-
(1996)
J Immunol
, vol.157
, pp. 3223-3227
-
-
Willenborg, D.O.1
Fordham, S.2
Bernard, C.C.3
-
186
-
-
0030456897
-
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice
-
Wolf S.D., Dittel B.N., Hardardottir F., et al. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996, 184:2271-2278.
-
(1996)
J Exp Med
, vol.184
, pp. 2271-2278
-
-
Wolf, S.D.1
Dittel, B.N.2
Hardardottir, F.3
-
187
-
-
0030961031
-
Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients - Identity of key contact residues in the B-cell and T-cell epitopes
-
Wucherpfennig K.W., Catz I., Hausmann S., et al. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients - Identity of key contact residues in the B-cell and T-cell epitopes. J Clin Invest 1997, 100:1114-1122.
-
(1997)
J Clin Invest
, vol.100
, pp. 1114-1122
-
-
Wucherpfennig, K.W.1
Catz, I.2
Hausmann, S.3
-
188
-
-
4744340401
-
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats
-
Yang J.S., Xu L.Y., Xiao B.G., et al. Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats. J Neuroimmunol 2004, 156:3-9.
-
(2004)
J Neuroimmunol
, vol.156
, pp. 3-9
-
-
Yang, J.S.1
Xu, L.Y.2
Xiao, B.G.3
-
189
-
-
0026506799
-
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin
-
Yednock T.A., Cannon C., Fritz L.C., et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992, 356:63-66.
-
(1992)
Nature
, vol.356
, pp. 63-66
-
-
Yednock, T.A.1
Cannon, C.2
Fritz, L.C.3
-
190
-
-
77953289016
-
Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis
-
York N.R., Mendoza J.P., Ortega S.B., et al. Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis. J Autoimmun 2010, 35:33-44.
-
(2010)
J Autoimmun
, vol.35
, pp. 33-44
-
-
York, N.R.1
Mendoza, J.P.2
Ortega, S.B.3
-
191
-
-
0029670711
-
Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis
-
Yu M., Nishiyama A., Trapp B.D., et al. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 1996, 64:91-100.
-
(1996)
J Neuroimmunol
, vol.64
, pp. 91-100
-
-
Yu, M.1
Nishiyama, A.2
Trapp, B.D.3
-
192
-
-
24344433564
-
Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions
-
Zhang Y., Da R.R., Hilgenberg L.G., et al. Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions. J Neuroimmunol 2005, 167:120-130.
-
(2005)
J Neuroimmunol
, vol.167
, pp. 120-130
-
-
Zhang, Y.1
Da, R.R.2
Hilgenberg, L.G.3
-
193
-
-
77953633327
-
TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis
-
Zhang H., Podojil J.R., Luo X., et al. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J Immunol 2010, 184:6629-6636.
-
(2010)
J Immunol
, vol.184
, pp. 6629-6636
-
-
Zhang, H.1
Podojil, J.R.2
Luo, X.3
|